Literature DB >> 6114039

Serotypes of attachment pili of enterotoxigenic Escherichia coli isolated from humans.

C F Deneke, G M Thorne, S L Gorbach.   

Abstract

Pili from enterotoxigenic Escherichia coli isolated from humans have been partially purified, and antisera have been prepared. These pili were initially attached to erythrocytes and then removed by thermal elution for purification. Three distinct antigenic types of pili have been identified. Antisera against these three pili types reacted with 60 of 106 (56%) enterotoxigenic E. coli isolated from humans but not with nontoxigenic, normal human fecal isolates of E. coli nor with enterotoxigenic E. coli strains isolated from animals. There was no correlation between pili serogroup and any of the following toxin production (heat labile, heat stable, or both), O antigenic type, geographical source of isolation, or mannose-resistant hemagglutination patterns of various erythrocyte types.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114039      PMCID: PMC351587          DOI: 10.1128/iai.32.3.1254-1260.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen.

Authors:  D G Evans; T K Satterwhite; D J Evans; H L DuPont
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  Inhibition of the interaction between fimbrial haemagglutinins and erythrocytes by D-mannose and other carbohydrates.

Authors:  D C Old
Journal:  J Gen Microbiol       Date:  1972-06

3.  Inhibitors of the adhesiveness of enteropathogenic E. coli.

Authors:  D A Rivier; M R Darekar
Journal:  Experientia       Date:  1975-06-15

4.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

5.  Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea.

Authors:  H W Smith; M A Linggood
Journal:  J Med Microbiol       Date:  1971-11       Impact factor: 2.472

6.  Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin.

Authors:  M M Levine; E S Caplan; D Waterman; R A Cash; R B Hornick; M J Snyder
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

7.  Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose.

Authors:  D J Evans; D G Evans; H L DuPont
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

8.  Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea.

Authors:  D G Evans; D J Evans; W S Tjoa; H L DuPont
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Special O:K:H serotypes among enterotoxigenic E. coli strains from diarrhea in adults and children. Occurrence of the CF (colonization factor) antigen and of hemagglutinating abilities.

Authors:  I Orskov; F Orskov
Journal:  Med Microbiol Immunol       Date:  1977-07-18       Impact factor: 3.402

10.  New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8.

Authors:  D G Evans; D J Evans
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

View more
  27 in total

1.  Design and characterization of highly immunogenic heat-stable enterotoxin of enterotoxigenic Escherichia coli K99(+).

Authors:  Nasr-Eldin M Aref; A Mahdi Saeed
Journal:  J Immunol Methods       Date:  2011-01-28       Impact factor: 2.303

2.  Production and characterization of monoclonal antibodies to a pilus colonization factor (colonization factor antigen III) of human enterotoxigenic Escherichia coli.

Authors:  T Honda; N Wetprasit; M Arita; T Miwatani
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Monoclonal antibodies against different epitopes on colonization factor antigen I of enterotoxin-producing Escherichia coli.

Authors:  Y Lopez-Vidal; P Klemm; A M Svennerholm
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

4.  Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans.

Authors:  A Cravioto; S M Scotland; B Rowe
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

5.  Colonization antigens and haemagglutination patterns of human Escherichia coli.

Authors:  J Blanco; E A González; R Anadón
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

6.  Experimental enterotoxin-induced Escherichia coli diarrhea and protection induced by previous infection with bacteria of the same adhesin or enterotoxin type.

Authors:  C M Ahrén; A M Svennerholm
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  New fimbrial antigenic type (E8775) that may represent a colonization factor in enterotoxigenic Escherichia coli in humans.

Authors:  L V Thomas; A Cravioto; S M Scotland; B Rowe
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

Review 8.  Enteropathogenicity: recent developments.

Authors:  E Neter
Journal:  Klin Wochenschr       Date:  1982-07-15

9.  Use of a known plasmid and transposon as tracers for the incompatibility classification of a cryptic plasmid.

Authors:  M S Judge; S Palchaudhuri
Journal:  Mol Gen Genet       Date:  1982

10.  Attachment of human and pig (K88) enterotoxigenic Escherichia coli strains to either human or porcine small intestinal cells.

Authors:  C F Deneke; K McGowan; A D Larson; S L Gorbach
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.